pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Endocrinology & Metabolism · news · pharmadog
← back to Endocrinology & Metabolism
News · Endocrinology & Metabolism
432
stories
13d
#AASLD26: Merck unwraps biopsy data for MASH drug it got from South Korea's Hanmi
endpoints
13d
STAT+: Beyond statins, one drug lowered heart attack risk by 20%
stat
13d
Coveted metabolic gem Rhythm reportedly gets $10B offer from AstraZeneca
biospace
13d
MetaVia sees GLP-1 shed liver fat and body weight in phase 1, takes aim at specific liver disease
fiercebiotech
14d
A treatment revolution is underway in MASH
biospace
14d
Novo gets much-needed lift as Wegovy pill tops Wall Street forecasts
biopharma dive
14d
AbbVie bets up to $1.47B for Nxera’s discarded IBD program
biospace
14d
Novo, Lilly battle for oral GLP-1 dominance with data tit for tat
biospace
14d
Q3 earnings roll on, FDA pushes rare disease, uniQure’s Huntington’s therapy reaches review
biospace
15d
Vertex, ahead of FDA decision, calms fears surrounding kidney drug
biopharma dive
15d
Neurocrine defends Prader-Willi drug after another patient death
biospace
19d
How Election Day can affect your heart
stat
19d
Earnings roundup: Lilly’s unwavering momentum, Novartis’ rebound and GSK’s waiting game
biopharma dive
20d
Merck looks ahead to ‘another year of investment’ as Keytruda cliff looms
biospace
20d
Flagship blends three biotech startups to form Etcelera
biopharma dive
21d
8 companies hiring in New York
biospace
21d
Flagship brings 3 biotech platforms together to launch AI drug discovery player Etcelera
fiercebiotech
21d
Oura, UC San Diego Health collaborate to study GLP-1 outcomes using continuous smart ring data
fiercebiotech
21d
Lilly’s ‘triple-G’ drug tops Novo’s Ozempic in diabetes trial
biopharma dive
21d
Lilly’s retatrutide trounces Novo’s Ozempic in diabetes, weight loss
biospace
21d
Opinion: Freezing my eggs showed me just how anti-feminist the fertility industry can be
stat
22d
Big Pharma is ready to strike, with J&J most likely to buy: Leerink
biospace
22d
‘The patient need is enormous’: Syntax programs stem cells into pancreatic beta cells in 4 days
fiercebiotech
22d
Gubra looks beyond metabolism, hopes for first portfolio company this year
endpoints
22d
STAT+: Pennsylvania Dutch country, tired of waiting for biopharma, builds drug company of its own
stat
23d
The 4 stages of women’s heart health: New framework for doctors and patients
stat
26d
STAT+: Diabetes association says ‘threat’ preceded members’ ejections, but admits policies were unclear
stat
27d
Top MAHA adviser Calley Means resigns from White House days ahead of midterms
stat
27d
Big trials push beyond obesity to see if GLP-1s can quell alcohol, drug cravings
endpoints
27d
Roche’s pipeline trim claims Poseida’s off-the-shelf CAR T asset
biospace
← prev
page 2 of 15
next →